All Stories

  1. Pathophysiology of Peritoneal Metastasis
  2. Surgical management of pancreatic neuroendocrine tumors – An EYSAC and E-AHPBA international survey of current practice
  3. Assessment of Intraoperative Scoring Systems for Predicting Cytoreduction Outcome in Peritoneal Metastatic Disease: A Systematic Review and Meta-analysis
  4. Development of a video-based deep learning model for differentiation of malignant and benign lesions during staging laparoscopy: Is the machine better than the expert?
  5. Standardizing eligibility and patient selection for Pressurized Intraperitoneal Aerosol Chemotherapy: A Delphi consensus statement
  6. Patients’ and carers’ views on research priorities in prehabilitation for cancer surgery
  7. Lymphatic spread patterns in young versus elderly patients with stage III colon cancer
  8. Early postoperative systemic inflammatory response as predictor of anastomotic leakage after esophagectomy: a systematic review and meta-analysis
  9. Current practice in assessment and management of malnutrition in surgical oncology practice – An ESSO-EYSAC snapshot analysis
  10. Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancer
  11. The empty pelvis syndrome: a core data set from the PelvEx collaborative
  12. Beating the empty pelvis syndrome: the PelvEx Collaborative core outcome set study protocol
  13. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis
  14. Systemic Inflammatory Response and the Noble and Underwood (NUn) Score as Early Predictors of Anastomotic Leakage after Esophageal Reconstructive Surgery
  15. Systemic Inflammatory Response and the Noble and Underwood (Nun) Score as Early Predictors of Anastomotic Leakage after Esophageal Reconstructive Surgery
  16. Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
  17. Hydraulic conductivity of human cancer tissue: A hybrid study
  18. Variations in the definition and perceived importance of positive resection margins in patients with colorectal cancer – an EYSAC international survey
  19. CO2-Driven Nebulization of pH-Sensitive Supramolecular Polymers for Intraperitoneal Hydrogel Formation and the Treatment of Peritoneal Metastasis
  20. 1550P Evaluating the novel combination of pressurized intraperitoneal aerosol chemotherapy-oxaliplatin (PIPAC-OX) as an immunomodulator in combination with systemic nivolumab for gastric cancer peritoneal metastases
  21. Smart hydrogels delivered by high pressure aerosolization can prevent peritoneal adhesions
  22. Empty pelvis syndrome: PelvEx Collaborative guideline proposal
  23. Drug transport modeling in solid tumors: A computational exploration of spatial heterogeneity of biophysical properties
  24. Effects of Hyperthermia and Hyperthermic Intraperitoneal Chemoperfusion on the Peritoneal and Tumor Immune Contexture
  25. Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients
  26. Research Priorities in Prehabilitation for Patients Undergoing Cancer Surgery: An International Delphi Study
  27. Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases
  28. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification
  29. SHARP risk score: A predictor of poor outcomes in adults admitted for emergency general surgery: A prospective cohort study
  30. Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases
  31. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
  32. Randomized controlled trials and alternative study designs in surgical oncology
  33. A preclinical platform for assessing long-term drug efficacy exploiting mechanically tunable scaffolds colonized by a three-dimensional tumor microenvironment
  34. Connecting the macro- and micro-scale properties in human solid tumors: hydraulic conductivity
  35. Morbidity and survival after laparoscopic versus open pancreatoduodenectomy: propensity score matched comparison
  36. Omentoplasty in Patients Undergoing Abdominoperineal Resection After Long-Course Chemoradiation for Locally Advanced and Locally Recurrent Rectal Cancer: A Comparative Single-Institution Cohort Study
  37. Electromotive Enhanced Drug Administration in Oncology: Principles, Evidence, Current and Emerging Applications
  38. Interstitial fluid pressure as an emerging biomarker in solid tumors
  39. Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
  40. Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
  41. The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study
  42. Optimization of intraperitoneal aerosolized drug delivery using computational fluid dynamics (CFD) modeling
  43. Incidence of lymph node recurrence after primary surgery for non-metastatic colon cancer: A systematic review
  44. Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer
  45. Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)
  46. Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative
  47. Patient‐reported outcomes after pelvic exenteration for colorectal cancer: A systematic review
  48. Biomechanical aspects of the normal and cancer-associated lymphatic system
  49. Anatomical and temporal patterns of lymph node metastasis in colorectal cancer
  50. Quality of Life after Minimally Invasive Esophagectomy: A Cross-Sectional Study
  51. Primary and metastatic peritoneal surface malignancies
  52. Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery
  53. The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
  54. Optimization of Intraperitoneal Aerosolized Drug Delivery: A Computational Fluid Dynamics (CFD) and Experimental Study
  55. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)
  56. Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: Technical aspects and treatment protocols
  57. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
  58. Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
  59. Hyperthermic Intraperitoneal Chemotherapy: A Critical Review
  60. Incidentally found mucinous epithelial tumors of the appendix with or without pseudomyxoma peritonei: diagnostic and therapeutic algorithms based on current evidence
  61. Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases: A first in human phase I study.
  62. Intraperitoneal EpCAM-Targeted Immunotoxin: A First Step Towards Engineering the Immune Environment in Colorectal Peritoneal Metastases?
  63. Hyperthermic Intraperitoneal Chemotherapy: A Critical Review
  64. Pressurized intraperitoneal aerosol chemotherapy in peritoneal carcinomatosis: is it all up in the air?
  65. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery
  66. Trace amounts of irinotecan found in the blood of a surgeon after performing HIPEC: what does it imply?
  67. The impact of molecular profile on the lymphatic spread pattern in stage III colon cancer
  68. Current practice and perceptions of safety protocols for the use of intraperitoneal chemotherapy in the operating room: results of the IP-OR international survey
  69. Impact of low anterior resection syndrome (LARS) on the quality of life and treatment options of LARS – A cross sectional study
  70. Society of Surgical Oncology SSO 2021 – International Conference on Surgical Cancer Care
  71. Debulking and HIPEC for ovarian cancer: effects of perfusion temperature on morbidity and cisplatin pharmacokinetics
  72. Electrostatic precipitation pressurized intraperitoneal aerosol chemotherapy (ePIPAC): Finding the optimal electrical potential
  73. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)
  74. Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification?
  75. The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma
  76. PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy
  77. Synergy between Intraperitoneal Aerosolization (PIPAC) and Cancer Nanomedicine: Cisplatin-Loaded Polyarginine-Hyaluronic Acid Nanocarriers Efficiently Eradicate Peritoneal Metastasis of Advanced Human Ovarian Cancer
  78. Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion
  79. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases
  80. Heating technology for malignant tumors: a review
  81. Intraperitoneal aerosolized drug delivery: Technology, recent developments, and future outlook
  82. Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review
  83. Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma
  84. Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis
  85. A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy
  86. A practical risk scale for predicting morbidity and mortality in the emergency general surgical setting: A prospective multi-center study
  87. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study
  88. HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
  89. Use of hyperthermia versus normothermia during intraperitoneal chemoperfusion with oxaliplatin for colorectal peritoneal carcinomatosis: A propensity score matched analysis
  90. Assessment of graft perfusion and oxygenation for improved outcome in esophageal cancer surgery
  91. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups
  92. Anorectal symptoms during pregnancy and postpartum: a prospective cohort study
  93. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)
  94. Pharmacokinetics and Tissue Transport of Intraperitoneal Chemotherapy
  95. Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis – a phase I first-in-human study
  96. The impact of surgical resection of the primary tumor on the development of synchronous colorectal liver metastasis: a systematic review
  97. Intraoperative radiation therapy for rectal cancer and recurrent intra-abdominal sarcomas
  98. Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE
  99. Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
  100. Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo
  101. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience
  102. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study
  103. Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer
  104. Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation
  105. Adipose-Derived Mesenchymal Stromal Cells Improve the Healing of Colonic Anastomoses Following High Dose of Irradiation Through Anti-Inflammatory and Angiogenic Processes
  106. Synergy between 5-HT4 receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle
  107. Tumour tissue transport after intraperitoneal anticancer drug delivery
  108. Effect of abdominopelvic sepsis on cancer outcome in patients undergoing sphincter saving surgery for rectal cancer
  109. High-Pressure Nebulization as Application Route for the Peritoneal Administration of siRNA Complexes
  110. Frailty as a predictor of mortality in the elderly emergency general surgery patient
  111. Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule
  112. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC)
  113. Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection
  114. Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis — Mission possible?
  115. The VEGFR Inhibitor Cediranib Improves the Efficacy of Fractionated Radiotherapy in a Colorectal Cancer Xenograft Model
  116. Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer
  117. The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score
  118. Age and cellular context influence rectal prolapse formation in mice with caecal wall colorectal cancer xenografts
  119. Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid
  120. Preclinical activity of melflufen (J1) in ovarian cancer
  121. Assessment of Ovarian Cancer Tumors Treated with Intraperitoneal Cisplatin Therapy by Nanoscopic X-ray Fluorescence Imaging
  122. Genipin-crosslinked gelatin microspheres as a strategy to prevent postsurgical peritoneal adhesions: In vitro and in vivo characterization
  123. Metabolic surgery in patients over 60 years old: short- and long-term results
  124. Data on in vivo selection of SK-OV-3 Luc ovarian cancer cells and intraperitoneal tumor formation with low inoculation numbers
  125. Lifelike Vascular Reperfusion of a Thiel-Embalmed Pig Model and Evaluation as a Surgical Training Tool
  126. Animal models of colorectal peritoneal metastasis
  127. Scoring histological regression in peritoneal carcinomatosis: does it count?
  128. BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis
  129. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei
  130. Colloidal stability of nano-sized particles in the peritoneal fluid: Towards optimizing drug delivery systems for intraperitoneal therapy
  131. Recent insights into the pathophysiology of omental metastases
  132. Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery
  133. A Model Based Analysis of IPEC Dosing of Paclitaxel in Rats
  134. Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis
  135. Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon
  136. Surgery, wound healing, and metastasis: Recent insights and clinical implications
  137. Clinical Research in Surgery: Threats and Opportunities
  138. Postmortem Pump-Driven Reperfusion of the Vascular System of Porcine Lungs: Towards a New Model for Surgical Training
  139. Molecular Imaging of Tumor-Associated Angiogenesis Using a Novel Magnetic Resonance Imaging Contrast Agent Targeting αvβ3 Integrin
  140. Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: Review of animal models
  141. Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin
  142. Recommendations for reporting outcome results in abdominal wall repair
  143. Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases
  144. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
  145. Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent
  146. Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members
  147. Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  148. Endovascular Treatment of an Iatrogenic Perforation of the Internal Iliac Vein
  149. Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project
  150. Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
  151. Development of a Nanocrystalline Paclitaxel Formulation for Hipec Treatment
  152. Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project
  153. Magnetic Electrospun Fibers for Cancer Therapy
  154. The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study
  155. Anastomotic Complications After Ivor Lewis Esophagectomy in Patients Treated With Neoadjuvant Chemoradiation Are Related to Radiation Dose to the Gastric Fundus
  156. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis
  157. Use of pneumatic nebulization and laser ablation–inductively coupled plasma–mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug
  158. Innovation in Cancer Imaging
  159. Progress in Rectal Cancer Treatment
  160. Variability of CT Contrast Enhancement in the Pancreas: A Cause for Concern?
  161. Tissue perfusion in pathologies of the pancreas: assessment using 128-slice computed tomography
  162. Flip angle optimization for dynamic contrast-enhanced MRI-studies with spoiled gradient echo pulse sequences
  163. First order correction for T2*-relaxation in determining contrast agent concentration from spoiled gradient echo pulse sequence signal intensity
  164. Assessment of Tumor Vascularization in Pancreatic Adenocarcinoma Using 128-Slice Perfusion Computed Tomography Imaging
  165. Malignant Peritoneal Mesothelioma in a Patient With Li-Fraumeni Syndrome
  166. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
  167. Antitumour Efficacy of Two Paclitaxel Formulations for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in an In Vivo Rat Model
  168. Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI
  169. Noninvasive Monitoring of Therapy-Induced Microvascular Changes in a Pancreatic Cancer Model Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging with P846, a New Low-Diffusible Gadolinium-Based Contrast Agent
  170. Long-Term Results of a Prospective Study on Laparoscopic Adjustable Gastric Banding for Morbid Obesity
  171. Conversion from Band to Bypass in Two Steps Reduces the Risk for Anastomotic Strictures
  172. Prognostic Value of the Lymph Node Ratio in Stage III Colorectal Cancer: A Systematic Review
  173. Laparoendoscopic Single-Site Gastrectomy for a Gastric GIST Using Double-Bended Instruments
  174. In vivo Toxicity and Bioavailability of Taxol® and a Paclitaxel/β-Cyclodextrin Formulation in a Rat Model During HIPEC
  175. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
  176. Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion in Women with Heavily Pretreated Recurrent Ovarian Cancer
  177. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence
  178. Letter 1: Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer (Br J Surg2009; 96: 982-989)
  179. Combined Effect of EPO and Radiotherapy on the Expression of Endogenous Molecular Markers of Tumor Metabolism and Metastasis
  180. An Unusual Post Gastrectomy Complication
  181. Preoperative chemoradiationversusradiation alone for stage II and III resectable rectal cancer: A systematic review and meta-analysis
  182. Total vs Partial Fundoplication in the Treatment of Gastroesophageal Reflux Disease
  183. In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC
  184. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
  185. Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment
  186. Attempted Suicide by Auto-Injection of Polyurethane (PU) Foam: Report of a Case
  187. Therapeutic Decision-Making in Endoscopically Unmanageable Nonvariceal Upper Gastrointestinal Hemorrhage
  188. Use of Laparoscopy for Rectal Cancer: A Word of Caution
  189. Safety and Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with High-Dose Oxaliplatin in Patients with Peritoneal Carcinomatosis
  190. Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion – Formulation and stability
  191. Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
  192. Neoadjuvant Chemoradiation Versus Hyperfractionated Accelerated Radiotherapy in Locally Advanced Rectal Cancer
  193. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
  194. Pre-operative combined modality therapy in the management of locally advanced rectal cancer
  195. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model
  196. Prospectively Randomized Trial Using Perioperative Low-dose Octreotide to Prevent Organ-related and General Complications after Pancreatic Surgery and Pancreatico-jejunostomy
  197. One- to Three-Year Results of Gastric Banding on Secondary Complications of Morbid Obesity in 625 Patients
  198. Functional Outcome Following Colon Interposition in Total Pharyngoesophagectomy with or without Laryngectomy
  199. The beneficial effects of supplementary glutamine on experimental irradiated colonic anastomosis; histological and morphological evaluation
  200. Surgical Treatment of Severe Obesity With a Low-Pressure Adjustable Gastric Band
  201. Determination of the K adsorption site on Fe() with XSW
  202. Influence of preoperative combined radiochemotherapy on surgical outcome and colonic anastomotic healing: experimental study in the rat
  203. The Swedish Laparoscopic Adjustable Gastric Banding for Morbid Obesity
  204. Influence of preoperative high-dose radiotherapy on postoperative outcome and colonic anastomotic healing
  205. Healing of experimental colonic anastomoses: Effects of combined preoperative high-dose radiotherapy and intraperitoneal 5-fluorouracil
  206. Authors' reply
  207. Das anpassbare Silicon Gastric Banding (ASGB, Bioenterics®) und das Schwedische anpassbare Gastric Banding (SAGB, Obtech®) zur Behandlung der morbiden Obesitas
  208. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer
  209. Morphology and composition of Au films on Si(100)
  210. Surgeons and the Internet
  211. Ultrathin Au layers on Si(100): surface silicide formation at room temperature
  212. Domain structure, segregation and morphology of the Pt3Sn(111) surface
  213. K adsorption on Fe(100) studied by X-ray standing waves
  214. Non-operative management of a splenic laceration in a patient with the Proteus syndrome.
  215. Substitutional adsorption of K on Fe(100)
  216. Caesium diffusion in sodium borosilicate glass studied by low-energy ion scattering